OUTCOMES AT 3 YEARS IN EBV plus EUROPEAN SUBPOPULATIONS FROM BENEFIT AND BENEFIT-EXT

被引：0
|
作者：
Budde, K. [1 ]
Blancho, G. [2 ]
Merville, P. [3 ]
Moal, M. -C. [4 ]
Rostaing, L. [5 ]
Harler, M. B. [6 ]
Grinyo, J. [7 ]
机构：
[1] Charite, D-13353 Berlin, Germany
[2] Univ Hosp Nantes, Nantes, France
[3] CHU Bordeaux, Bordeaux, France
[4] CHU Brest, F-29285 Brest, France
[5] CHU Toulouse, Toulouse, France
[6] Bristol Myers Squibb Co, Princeton, NJ USA
[7] Hosp Univ Bellvitge, Barcelona, Spain
来源：
TRANSPLANT INTERNATIONAL | 2014年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
P030
引用
收藏
页码：33 / 33
页数：1
相关论文
共 50 条
  • [31] Belatacept vs Cyclosporine in ECD Kidney Transplants: Two-Year Outcomes from the BENEFIT-EXT Study
    Durrbach, A.
    Larsen, C. P.
    Pestana, J. Medina
    Vanrenterghem, Y.
    Vincenti, F.
    Florman, S.
    Xing, J.
    Block, A.
    Garg, P.
    Grinyo, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 83 - 83
  • [32] BELATACEPT VS CYCLOSPORINE IN ECD KIDNEY TRANSPLANTS: TWO-YEAR OUTCOMES FROM THE BENEFIT-EXT STUDY
    Durrbach, A.
    Larsen, C.
    Medina Pestana, J.
    Vanrenterghem, Y.
    Vincenti, F.
    Florman, S.
    Xing, J.
    Block, A.
    Garg, P.
    Grinyo, J.
    TRANSPLANT INTERNATIONAL, 2010, 23 : 59 - 59
  • [33] Efficacy and Safety Outcomes of Extended Criteria Donor Kidneys by Subtype: Subgroup Analysis of BENEFIT-EXT at 7 Years After Transplant
    Florman, S.
    Becker, T.
    Bresnahan, B.
    Chevaile-Ramos, A.
    Carvalho, D.
    Grannas, G.
    Muehlbacher, F.
    O'Connell, P. J.
    Meier-Kriesche, H. U.
    Larsen, C. P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (01) : 180 - 190
  • [34] Obesity is associated with a higher incidence of rejection in patients on belatacept: A pooled analysis from the BENEFIT/BENEFIT-EXT clinical trials
    Lange, Nicholas W.
    King, Kristen
    Husain, Syed Ali
    Salerno, David M.
    Tsapepas, Demetra S.
    Hedvat, Jessica
    Yu, Miko
    Mohan, Sumit
    AMERICAN JOURNAL OF TRANSPLANTATION, 2024, 24 (06) : 1027 - 1034
  • [35] Validation of the iBox Surrogate End Point in CNI Free, Belatacept Treated Patients (BENEFIT & BENEFIT-EXT).
    Divard, G.
    Aubert, O.
    Raynaud, M.
    Vincenti, F.
    Rostaing, L.
    Durbach, A.
    Legendre, C.
    Vadanici, R.
    Loupy, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 512 - 512
  • [36] Three-Year Outcomes by Donor Type in Phase III Studies of Belatacept vs Cyclosporine in Kidney Transplantation (BENEFIT & BENEFIT-EXT)
    Florman, S.
    Becker, T.
    Bresnahan, B.
    Chevaile-Ramos, A.
    DeCarvalho, D.
    Muehlbacher, F.
    O'Connell, P.
    Duan, T.
    Agarwal, M.
    Larsen, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 100 - 100
  • [37] The External Validation of the Cardiovascular Risk Equation for Renal Transplant Recipients: Applications to BENEFIT and BENEFIT-EXT Trials
    Soveri, Inga
    Snyder, Jon
    Holdaas, Hallvard
    Holme, Ingar
    Jardine, Alan G.
    L'Italien, Gilbert J.
    Fellstrom, Bengt
    TRANSPLANTATION, 2013, 95 (01) : 142 - 147
  • [38] Likelihood of Improving or Sustaining Renal Function over Three Years with Belatacept or CsA: Insights from the BENEFIT-EXT Study
    Grinyo, J.
    Medina Pestana, J.
    Becker, T.
    Rial, M. C.
    Dong, Y.
    Block, A.
    Durrbach, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 82 - 82
  • [39] RENAL FUNCTION IN PATIENTS TREATED WITH BELATACEPT-OR CYCLOSPORINE-BASED REGIMENS AT YEAR 3 IN THE BENEFIT AND BENEFIT-EXT STUDIES
    Durrbach, Antoine
    Citterio, Franco
    Mulloy, Laura
    David-Neto, Elias
    Russ, Graeme
    Vitko, Sefan
    Zhang, Rubin
    Xing, Jun
    Harler, Mary Beth
    Grinyo, Josep
    TRANSPLANT INTERNATIONAL, 2011, 24 : 249 - 249
  • [40] 5-YEAR OUTCOMES BY DONOR TYPE FROM THE LONG-TERM EXTENSION OF THE BELATACEPT BENEFIT-EXT STUDY
    Muehlbacher, Ferdinand
    Florman, Sander
    Zhang, Rubin
    Lang, Philippe
    Lehner, Frank
    Massari, Pablo
    Garcia, Valter D.
    Pupim, Lara
    Durrbach, Antoine
    TRANSPLANT INTERNATIONAL, 2013, 26 : 92 - 92
12345